{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:13:50Z","timestamp":1786119230424,"version":"build-2736575974"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1097\/jcp.0b013e3181a497d7","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T08:47:24Z","timestamp":1242895644000},"page":"291-295","source":"Crossref","is-referenced-by-count":35,"title":["A Double-Blind, Placebo-Controlled Pilot Study of Galantamine to Improve Cognitive Dysfunction in Minimally Symptomatic Bipolar Disorder"],"prefix":"10.1097","volume":"29","author":[{"given":"S. Nassir","family":"Ghaemi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William S.","family":"Gilmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert T.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"Hanlon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Kemp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber D.","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyvia","family":"Chriki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan M.","family":"Filkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip D.","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"suppl","key":"R1-17-20210128","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1192\/bjp.178.41.s120","article-title":"Neuropsychology of bipolar disorder.","volume":"41","author":"Murphy","year":"2001","journal-title":"Br J Psychiatry"},{"key":"R2-17-20210128","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1176\/appi.ajp.158.10.1605","article-title":"A neuropsychological investigation of prefrontal cortex involvement in acute mania.","volume":"158","author":"Clark","year":"2001","journal-title":"Am J Psychiatry"},{"key":"R3-17-20210128","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1034\/j.1399-5618.2001.030207.x","article-title":"Neuropsychological frontal lobe tests indicate that bipolar depressed patients are more impaired than unipolar.","volume":"3","author":"Borkowska","year":"2001","journal-title":"Bipolar Disord"},{"key":"R4-17-20210128","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/S0006-3223(00)00910-0","article-title":"Neuropsychologic impairments in bipolar and unipolar mood disorders on the CANTAB neurocognitive battery.","volume":"48","author":"Sweeney","year":"2000","journal-title":"Biol Psychiatry"},{"key":"R5-17-20210128","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1176\/ajp.156.1.139","article-title":"Frontosubcortical neuroanatomy and the continuous performance test in mania.","volume":"156","author":"Sax","year":"1999","journal-title":"Am J Psychiatry"},{"key":"R6-17-20210128","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1017\/S0033291799001233","article-title":"Emotional bias and inhibitory control processes in mania and depression.","volume":"29","author":"Murphy","year":"1999","journal-title":"Psychol Med"},{"key":"R7-17-20210128","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0006-3223(98)00148-6","article-title":"Neuropsychological performance of monozygotic twins discordant for bipolar disorder.","volume":"45","author":"Gourovitch","year":"1999","journal-title":"Biol Psychiatry"},{"key":"R8-17-20210128","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0165-1781(01)00242-6","article-title":"Cognitive function in euthymic bipolar I disorder.","volume":"102","author":"Zubieta","year":"2001","journal-title":"Psychiatry Res"},{"key":"R9-17-20210128","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1034\/j.1399-5618.2001.030206.x","article-title":"Electrophysiological and cognitive function in young euthymic patients with bipolar affective disorder.","volume":"3","author":"El-Badri","year":"2001","journal-title":"Bipolar Disord"},{"key":"R10-17-20210128","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s004060070015","article-title":"Cognitive symptoms of mania in pure and mixed episodes evaluated with the Positive and Negative Syndrome Scale.","volume":"250","author":"Rossi","year":"2000","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"R11-17-20210128","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1192\/bjp.175.3.246","article-title":"Neuropsychological function in euthymic patients with bipolar disorder.","volume":"175","author":"Ferrier","year":"1999","journal-title":"Br J Psychiatry"},{"key":"R12-17-20210128","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/0006-3223(90)90416-Y","article-title":"Cognitive impairment and cerebral structure by MRI in bipolar disorder.","volume":"27","author":"Coffman","year":"1990","journal-title":"Biol Psychiatry"},{"key":"R13-17-20210128","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1001\/archpsyc.1990.01810130057008","article-title":"Subcortical abnormalities detected in bipolar affective disorder using magnetic resonance imaging.","volume":"47","author":"Dupont","year":"1990","journal-title":"Arch Gen Psychiatry"},{"key":"R14-17-20210128","first-page":"227","article-title":"Relationship between prior course of illness and neuroanatomic structures in bipolar disorder: a preliminary study.","volume":"14","author":"Ali","year":"2001","journal-title":"Neuropsychiatry Neuropsychol Behav Neurol"},{"key":"R15-17-20210128","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0165-0327(99)00028-2","article-title":"Relationship between prior course of illness and neuropsychological functioning in patients with bipolar disorder.","volume":"56","author":"Denicoff","year":"1999","journal-title":"J Affect Disord"},{"key":"R16-17-20210128","first-page":"120","article-title":"Cognitive deficits, psychopathology, and psychosocial functioning in bipolar mood disorder.","volume":"11","author":"Atre-Vaidya","year":"1998","journal-title":"Neuropsychiatry Neuropsychol Behav Neurol"},{"key":"R17-17-20210128","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1212\/WNL.54.12.2261","article-title":"Galantamine in AD: a 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group.","volume":"54","author":"Raskind","year":"2000","journal-title":"Neurology"},{"key":"R18-17-20210128","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1212\/WNL.54.12.2269","article-title":"A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group.","volume":"54","author":"Tariot","year":"2000","journal-title":"Neurology"},{"key":"R19-17-20210128","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1136\/bmj.321.7274.1445","article-title":"Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group.","volume":"321","author":"Wilcock","year":"2000","journal-title":"BMJ"},{"key":"R20-17-20210128","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/jnnp.71.5.589","article-title":"Effects of a flexible galantamine dose in Alzheimer's disease: a randomised, controlled trial.","volume":"71","author":"Rockwood","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R21-17-20210128","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/ajhp\/58.8.649a","article-title":"FDA approves galantamine for Alzheimer's disease.","volume":"58","author":"Thompson","year":"2001","journal-title":"Am J Health Syst Pharm"},{"key":"R22-17-20210128","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/gps.409","article-title":"Galantamine: a randomized, double-blind, dose comparison in patients with Alzheimer's disease.","volume":"16","author":"Wilkinson","year":"2001","journal-title":"Int J Geriatr Psychiatry"},{"key":"R23-17-20210128","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/msj.20042","article-title":"Bipolar disorder: candidate drug targets.","volume":"75","author":"Zarate","year":"2008","journal-title":"Mt Sinai J Med"},{"key":"R24-17-20210128","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1399-5618.2006.00311.x","article-title":"Galantamine treatment of cognitive impairment in bipolar disorder: four cases.","volume":"8","author":"Schrauwen","year":"2006","journal-title":"Bipolar Disord"},{"key":"R25-17-20210128","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1176\/appi.ajp.2007.07050724","article-title":"Galantamine for the treatment of cognitive impairments in people with schizophrenia.","volume":"165","author":"Buchanan","year":"2008","journal-title":"Am J Psychiatry"},{"key":"R29-17-20210128","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/sj.npp.1301499","article-title":"Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo\/practice effects in a 12-week, randomized, double-blind, placebo-controlled trial.","volume":"33","author":"Keefe","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"R30-17-20210128","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/WNF.0b013e318059be76","article-title":"Add-on therapy with acetylcholinesterase inhibitors for memory dysfunction in schizophrenia: a systematic quantitative review, part 2.","volume":"30","author":"Stip","year":"2007","journal-title":"Clin Neuropharmacol"},{"key":"R31-17-20210128","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jad.2007.07.027","article-title":"Is donepezil useful for improving cognitive dysfunction in bipolar disorder?","volume":"107","author":"Kelly","year":"2008","journal-title":"J Affect Disord"},{"key":"R32-17-20210128","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1185\/030079906X167372","article-title":"Rivastigmine treatment as an add-on to antipsychotics in patients with schizophrenia and cognitive deficits.","volume":"23","author":"Chouinard","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"R33-17-20210128","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1590\/S0004-282X2004000300001","article-title":"Effects of galantamine on attention and memory in Alzheimer's disease measured by computerized neuropsychological tests: results of the Brazilian Multi-Center Galantamine Study (GAL-BRA-01).","volume":"62","author":"Caramelli","year":"2004","journal-title":"Arq Neuropsiquiatr"},{"key":"R34-17-20210128","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neurobiolaging.2004.12.005","article-title":"Inhibition of hippocampal function in mild cognitive impairment: targeting the cholinergic hypothesis.","volume":"27","author":"Gron","year":"2006","journal-title":"Neurobiol Aging"},{"key":"R35-17-20210128","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.mehy.2005.09.037","article-title":"Neuropharmacology of cognition and memory: a unifying theory of neuromodulator imbalance in psychiatry and amnesia.","volume":"66","author":"Vakalopoulos","year":"2006","journal-title":"Med Hypotheses"},{"issue":"suppl 1","key":"R36-17-20210128","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1038\/sj.mp.4001019","article-title":"Role of the cholinergic muscarinic system in bipolar disorder and related mechanism of action of antipsychotic agents.","volume":"7","author":"Bymaster","year":"2002","journal-title":"Mol Psychiatry"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004714-200906000-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:50:28Z","timestamp":1786038628000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004714-200906000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e3181a497d7","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}